Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06161441
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2023-11-29
Brief Title:
A Trial to Learn if the Combination of Fianlimab Cemiplimab and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals